PWMG
ABUS icon

Private Wealth Management Group’s Arbutus Biopharma ABUS Stock Holding History

Private Wealth Management Group’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.09K Hold
242
– – ﹤0.01% 1237
2025
Q4 		$1.17K Hold
242
– – ﹤0.01% 1228
2025
Q3 		$1.1K Hold
242
– – ﹤0.01% 1260
2025
Q2 		$748 Hold
242
– – ﹤0.01% 1340
2025
Q1 		$845 Hold
242
– – ﹤0.01% 1306
2024
Q4 		$792 Hold
242
– – ﹤0.01% 1351
2024
Q3 		$932 Hold
242
– – ﹤0.01% 1304
2024
Q2 		$748 Hold
242
– – ﹤0.01% 1354
2024
Q1 		$625 Hold
242
– – ﹤0.01% 1395
2023
Q4 		$605 Buy
+242
New +$474 ﹤0.01% 1423

Other funds holding ABUS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return